bioRxivCell BiologyPreprint
Myeloid Cell-Derived IL1β Contributes to Pulmonary Vascular Remodeling in Heart Failure with Preserved Ejection Fraction
V. Agrawal, J. A. Kropski, J. J. Gokey, E. Kobeck, M. B. Murphy, K. T. Murray, N. L. Fortune, C. S. Moore, D. F. Meoli, K. Monahan, Y. R. Su, T. Blackwell, D. K. Gupta, M. H. Talati, E. J. Carrier, J. D. West, A. R. Hemnes
Abstract
BackgroundPulmonary hypertension (PH) in heart failure with preserved ejection fraction (HFpEF) is a common and highly morbid syndrome, but mechanisms driving PH-HFpEF are not well understood. We sought to determine whether a well-accepted murine model of HFpEF also displays features of PH in HFpEF, and we sought to identify pathways that might drive early remodeling of the pulmonary vasculature in HFpEF. MethodsEight week old male and female C57/BL6J mice were given either L-NAME and high fat diet (HFD) or control water/diet for 2,5, and 12 weeks. Bulk RNA sequencing and single cell RNA sequencing was performed to identify early and cell-specific pathways that might regulate pulmonary vascular remodeling in PH-HFpEF. Finally, clodronate liposome and IL1{beta} antibody treatments were utilized to deplete macrophages or IL1{beta}, respectively, to assess their impact on pulmonary vascular remodeling in HFpEF. ResultsMice given L-NAME/HFD developed PH, small vessel muscularization, and right heart dysfunction after 2 weeks of treatment. Inflammation-related gene ontologies were over-represented in bulk RNA sequencing analysis of whole lungs, with an increase in CD68+ cells in both murine and human PH-HFpEF lungs. Cytokine profiling of mouse lung and plasma showed an increase in IL1{beta}, which was confirmed in plasma from patients with HFpEF. Single cell sequencing of mouse lungs also showed an increase in M1-like, pro-inflammatory populations of Ccr2+ monocytes and macrophages, and transcript expression of IL1{beta} was primarily restricted to myeloid-type cells. Finally, clodronate liposome treatment prevented the development of PH in L-NAME/HFD treated mice, and IL1{beta} antibody treatment also attenuated PH in L-NAME/HFD treated mice. ConclusionsOur study demonstrated that a well-accepted model of HFpEF recapitulates features of pulmonary vascular remodeling commonly seen in patients with HFpEF, and we identified myeloid cell derived IL1{beta} as an important contributor to PH in HFpEF.
- organism: mouse
- assay: bulk RNA-seq
- assay: scRNA-seq
- research focus: cell type annotation
- research focus: differential expression
- research focus: cell-cell communication
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Myeloid cell recruitment propels right ventricular dysfunction in HFpEF via sterile inflammation.
Lara Jaeschke, Ceren Koçana, … Jana Grune·CirculationPeer-reviewed·Aug 18, 2026
- Liver angiocrine myeloid-derived growth factor protects against endothelial dysfunction in pulmonary arterial hypertension
Navneet Singh, Talia Volpicelli, … Olin D. Liang·bioRxiv·Oct 3, 2025
- Levosimendan Ameliorates Adverse Pulmonary Vascular Remodeling in Group-2 Pulmonary Hypertension.
Antonella Abi-Sleimen, Ruaa Al‐Qazazi, … François Potus·bioRxiv·Oct 23, 2025
- Blocking Interleukin-1β transiently limits left ventricular dilation and reduces cardiac lymphangiogenesis during pressure-overload in mice
C. Heron, T. Lemarcis, … E. Brakenhielm·bioRxiv·Apr 1, 2023
- Immunoregulatory macrophages modify local pulmonary immunity and ameliorate hypoxic-pulmonary hypertension
A. Fernandez-Gonzalez, A. Mukhia, … S. Kourembanas·Arteriosclerosis, Thrombosis, and Vascular BiologyPeer-reviewed·Dec 1, 2024
- Bone marrow mesenchymal stromal cells mediate cellular inflammation in HFpEF
Kyle I. Mentkowski, I‐Hsiu Lee, … Matthias Nahrendorf·bioRxiv·Mar 28, 2025